Skip to main content

Animations

MJFF Publications

7531 - 7540 of 9033 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2014
  • 2024
  • 2021
  • 2025
  • 2026
  • 2025
  • 2018
  • 2026
  • Summary Details
    OPEN
    Title: Predicting longitudinal brain atrophy in Parkinson’s disease using a Susceptible-Infected-Removed agent-based model
    Journal Name: Network Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/netn_a_00296
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Identifying Protective Drugs for Parkinson's Disease in Health‐Care Databases Using Machine Learning
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/mds.29205
    Citation Count: 17
  • The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
    2014
    Summary Details
    RESTRICTED
    Title: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
    Journal Name: Journal of the American Chemical Society
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/ja411577t
    Citation Count: 257
  • Summary Details
    OPEN
    Title: Evaluation of Protein Identification and Quantification by the diaPASEF Method on timsTOF SCP
    Journal Name: Journal of the American Society for Mass Spectrometry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/jasms.4c00067
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
    Journal Name: Frontiers in Cellular Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fncel.2021.626128
    Citation Count: 123
  • Summary Details
    OPEN
    Title: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00896-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's Disease
    Journal Name: Journal of Extracellular Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/jex2.70116
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Hemispheric lateralization of dopamine transporter binding in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002
    Citation Count: 50
  • Summary Details
    OPEN
    Title: Speech Impairment in Early Parkinson’s Disease Is Associated with Nigrostriatal Dopaminergic Dysfunction
    Journal Name: Journal of Clinical Medicine
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3390/jcm15031006
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.